Hayley Mitchell
Physician Assistant · Wilmington, NCNPI 1346847860
Payments from drug & device makers
Across 184 payments — averaging $24.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$838
- Johnson & Johnson$601
- AbbVie$594
- Alkermes, Inc.$421
- Neurocrine Biosciences, Inc.$341
- E.r. Squibb & Sons, L.L.C.$318
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,518100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $838 |
| Johnson & Johnson | 17 | $601 |
| AbbVie | 67 | $594 |
| Alkermes, Inc. | 17 | $421 |
| Neurocrine Biosciences, Inc. | 6 | $341 |
| E.r. Squibb & Sons, L.L.C. | 5 | $318 |
| Teva Pharmaceuticals USA, Inc. | 7 | $293 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $262 |
| Vanda Pharmaceuticals Inc. | 7 | $152 |
| USWM, LLC | 6 | $144 |
| Axsome Therapeutics, Inc. | 1 | $108 |
| Supernus Pharmaceuticals, Inc. | 1 | $107 |
| Indivior Inc. | 5 | $95 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $70 |
| Corium, LLC | 4 | $65 |
| Tolmar, Inc. | 1 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,518 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 11 | $81,186 |
| Aripiprazole | 19 | $1,056 |
| Buprenorphine Hcl | 13 | $538 |
| Prazosin Hcl | 12 | $182 |
| Hydroxyzine Pamoate | 24 | $179 |
| Olanzapine | 11 | $118 |
| Trazodone Hcl | 31 | $112 |
| Lamotrigine | 23 | $108 |
| Sertraline Hcl | 12 | $93 |
| Clonazepam | 32 | $80 |
| Quetiapine Fumarate | 19 | $72 |
| Ropinirole Hcl | 11 | $64 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $27 |
| Zolpidem Tartrate | 18 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $293 | $81,18611 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $9312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Wilmington
- Leighton MorganWilmington$21K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.